Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high36.350 17/01/17
52 week low25.000 12/12/17
52 week change -5.625 (-17.79%)
4 week volume4,421,186 18/11/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

New CE mark granted for Silhouette Soft

Miscellaneous medium priority announcements

Hardman Research: Demand growing in target markets

Interim Results

Announcement of half-year/second quarter financial results

Holding(s) in Company

Notification of major interests in shares

Hardman Research: Promising start in the US

Sinclair Pharma lifts sales in 6 months to 30 June

Sinclair Pharma said its unaudited sales for the six months to 30 June were 20m, compared with sales of 17.2m for the sam...

Sinclair Pharma lifts sales in 6 months to 30 June

Trading Update for the 6 months to 30 June 2017

Statement regarding a company’s trading performance (e.g. profit warning)

Fundamental DataMore

EPS-5.9
Dividend yield0 %

Latest discussion posts More

  • CE registration

    RNS: 19/10/2017: New CE mark granted for Silhouette Soft?. Probably what has prompted the move up as people realise that the product has a globally recognised status as an EU ...
    23-Oct-2017
    PharmaD
  • Re: Interims

    Pretty much what the trading update said in July. It didn't impress the markets then as judged by the drift downwards.
    19-Sep-2017
    Red Ninja
  • Interims

    Revenue up 16%, strong 2nd half growth forecast and prediction of EDITDA profit for full year 2017. Slight worry that they have pretty much burnt through their cash pile ...
    19-Sep-2017
    charlus

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account